The Quantellect read.As of Nov 19, 2026, 11 active firms cover Invesco Plc: 6 rate it Buy or better, 5 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $29.50 to $41.00, so the covering firms are broadly aligned. The average target of $33.68 sits 18% above the current $28.66. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.72 next quarter toward $3.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Buy
Strong Buy00%
Buy655%
Neutral545%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$33.68
+17.5% upside
Average target across 11 active firms as of Nov 19, 2026 vs $28.66 current
Highest Target$41.00
Average Target$33.68
Lowest Target$29.50
Detailed analyst forecasts for IVZ
Showing 1–11 of 11 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 6 of 11 active firms rate IVZ a Buy (5 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IVZ EPS & revenue forecast
EPS · NEXT QUARTER
$0.72
Range $0.69 – $0.73 · 10 analysts · +26% YoY
Next period, 10 analysts expect Invesco Plc to earn $0.72 a share (range $0.69 – $0.73), versus $0.57 a year earlier. Full-year consensus is $2.78, growing to $3.30 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.4B · 10 analysts · +9% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.4B), +9.4% year-over-year. Full-year consensus is $5.4B, rising to $5.8B next year.
Top analysts covering Invesco Plc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IVZ.
#1
Alexander Blostein
Goldman Sachs · Rank #52
Neutral
$33.00+15.1% to target
Overall win rate
56%
+ Follow
#2
Benjamin Budish
Barclays · Rank #180
Neutral
$32.00+11.7% to target
Overall win rate
44%
+ Follow
#3
Kenneth S. Lee
RBC Capital · Rank #313
Buy
$36.00+25.6% to target
Overall win rate
31%
+ Follow
#4
Michael Cyprys
Morgan Stanley · Rank #358
Neutral
$32.00+11.7% to target
Overall win rate
38%
+ Follow
#5
Glenn Schorr
Evercore ISI Group
Neutral
$34.00+18.6% to target
Coverage
—
+ Follow
IVZ stock forecast FAQ
What is IVZ's average 12-month price target?+
The 11 active firms with a live target average $33.68 for Invesco Plc over the next 12 months, ranging from a $41.00 high to a $29.50 low, as of Nov 19, 2026.
Is IVZ stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 11 active firms as of Nov 19, 2026, 6 rate it Buy or Strong Buy, 5 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IVZ?+
The Street-high target is $41.00, and the Street-low is $29.50 (JP Morgan). The average of all 11 active-firm targets is $33.68.
How many active Wall Street firms cover IVZ?+
11 active firms have a recognized rating on Invesco Plc as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IVZ?+
Among analysts who currently cover IVZ, Alexander Blostein of Goldman Sachs has the strongest overall Quantellect track record (Rank #52). Their current call is Neutral with a $33.00 target.
What is Invesco Plc's projected EPS for next quarter?+
The consensus estimate is $0.72 per share (range $0.69 – $0.73) across 10 analysts. Full-year EPS is projected at $2.78, rising to $3.30 the following year.
How much revenue is Invesco Plc expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.4B). Full-year revenue is projected at $5.4B, growing to $5.8B next year.
Have analysts been upgrading or downgrading IVZ lately?+
As of Nov 19, 2026, 6 of 11 active firms rate IVZ a Buy (5 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IVZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.